Ford to inject up to $4.76 billion into German business, FT reports-March 2024-www.financetom.com

Ford to inject up to $4.76 billion into German business, FT reports

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Ford to inject up to $4.76 billion into German business, FT reports

Mar 10, 2025 2:48 AM

March 10 (Reuters) - Ford Motor ( F ) will inject up to

EUR 4.4 billion ($4.76 billion) into its struggling German unit

as it tries to revive its car business in Europe, the Financial

Times reported on Monday.

($1 = 0.9249 euros)

(Reporting by Shivansh Tiwary in Bengaluru; Editing by Mrigank

Dhaniwala)

Previous page： Eight international oil companies reach agreement with Iraq, KRG to resume oil exports Next page： Flowers Foods CFO Steve Kinsey to Retire at Yearend

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Eight international oil companies reach agreement with Iraq, KRG to resume oil exports

Sep 24, 2025

Sept 24 (Reuters) - The eight international oil companies operating in Iraqi Kurdistan reached agreements in principle with Iraq's federal and Kurdish regional governments to resume oil exports, according to an IOC statement seen by Reuters on Wednesday. The agreed framework, once signed and implemented, will allow exports to restart in the coming days, the statement said. Norway's DNO, and...

Flowers Foods CFO Steve Kinsey to Retire at Yearend

Sep 24, 2025

09:35 AM EDT, 09/24/2025 (MT Newswires) -- Flowers Foods ( FLO ) said Wednesday that Steve Kinsey plans to retire as the company's chief financial officer at the end of the year. The company said it has started a search for its new CFO. Kinsey is expected to remain in an advisory role for a period of time to ensure...

TG Therapeutics Says 6-Year Briumvi Data Show 90% of Multiple Sclerosis Patients Free From Progression

Sep 24, 2025

09:43 AM EDT, 09/24/2025 (MT Newswires) -- TG Therapeutics ( TGTX ) said Wednesday that new data from phase 3 trials assessing Briumvi showed that 89.9% of relapsing multiple sclerosis patients were free from disability progression during the sixth year of continuous treatment. The company said 10.1% of patients had confirmed disability progression that lasted 24 weeks compared with patients...

Fermi America™ Announces Launch of Initial Public Offering

Sep 24, 2025

AMARILLO, Texas, Sept. 24, 2025 /PRNewswire/ -- Fermi LLC (to be converted into Fermi Inc. prior to the effectiveness of its Registration Statement on Form S-11) (Fermi America) announced today that it has launched the roadshow for its proposed initial public offering of 25,000,000 shares of its common stock. In addition, Fermi America intends to grant the underwriters a 30-day...